Zai Lab Ltd 2022 SR
The report outlines Zai Lab's 'Trust for Life' ESG strategy, focusing on improving human health, creating better outcomes, and acting right now. Key highlights include reaching 222,000 patients in 2022, maintaining gender equity in leadership and base pay, and completing a comprehensive Scope 1, 2, and 3 GHG inventory. The company committed to the Science Based Targets initiative (SBTi) and aims to reach one million patients by 2030. Additionally, Zai Lab advanced its global pipeline with over 22 drug candidates and established a Global Occupational Health and Safety management system.
Company: Zai Lab Ltd
Sector: Health Care
Country: China
Year: 2022
Type: SR
Pages: 52
Zai Lab Ltd
ESG Report
The report outlines Zai Lab's 'Trust for Life' ESG strategy, focusing on improving human health, creating better outcomes, and acting right now. Key highlights include reaching 222,000 patients in 2022, maintaining gender equity in leadership and base pay, and completing a comprehensive Scope 1, 2, and 3 GHG inventory. The company committed to the Science Based Targets initiative (SBTi) and aims to reach one million patients by 2030. Additionally, Zai Lab advanced its global pipeline with over 22 drug candidates and established a Global Occupational Health and Safety management system.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2022
Reporting Period
Jan 1, 2022 - Dec 31, 2022
Fiscal Year
2022
Published
Jul 1, 2023
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Sustainable Development Goals
Other Standards
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Energy Consumption
Water Consumption
Total Waste
Women in Management
Workplace Fatalities
Employees